SUMMARY Wnt/β-catenin signaling is a central regulator of adult stem cells. Variable sensitivity of Wnt reporter transgenes, β-catenin’s dual roles in adhesion and signaling, and hair follicle degradation and inflammation resulting from broad deletion of epithelial β-catenin, have precluded clear understanding of Wnt/β-catenin’s functions in adult skin stem cells. By inducibly deleting β-catenin globally in skin epithelia, only in hair follicle stem cells, or only in interfollicular epidermis, and comparing the phenotypes with those caused by ectopic expression of the Wnt/β-catenin inhibitor Dkk1, we show that this pathway is necessary for hair follicle stem cell proliferation. However, β-catenin is not required within hair follicle stem cells for their maintenance, and follicles resume proliferating after removal of ectopic Dkk1, indicating persistence of functional progenitors. We further unexpectedly discovered a broader role for Wnt/β-catenin signaling in contributing to progenitor cell proliferation in non-hairy epithelia and interfollicular epidermis under homeostatic, but not inflammatory, conditions.

IntroductionAngiogenesis is a critical process in physiologic and pathologic conditions, including embryo development, wound healing, tumor progression, and inflammatory diseases. 1 Inflammation and angiogenesis are closely associated, and pathologic angiogenesis has been implicated in the development of chronic inflammatory diseases. Interplay between inflammation and angiogenesis is mediated largely by cytokines, chemokines, and growth factors. Some of these molecules, including vascular endothelial growth factor (VEGF), induce endothelial permeability, allowing the infiltration of leukocytes to inflammatory sites, resulting in tissue damage. 2 Interleukin-33 (IL-33) is a newly identified cytokine of the IL-1 family, which also includes the inflammatory cytokines IL-1␣, It has been shown to signal via ST2 receptor. 4 IL-33 expression is broadly detected in various tissues, including stomach, lung, spinal cord, brain, and skin, as well as in cells, including smooth muscle cells and epithelial cells lining bronchus and small airways. 4 Notably, IL-33 expression is induced by IL-1␤ and tumor necrosis factor-␣ (TNF-␣) in lung and dermal fibroblast and, to a lesser extent, by macrophage activation. 4 IL-33 treatment has been shown to induce T-helper (Th) type 2 responses in mice as indicated by an increase in Th2 cytokine production and serum immunoglobulin. Systemic treatment of mice with IL-33 results in pathologic changes in the lung and the digestive tract. In the lung, vascular changes accompanied with eosinophilic and mononuclear infiltrates were observed in small muscular arteries. 4 Recently, functions of IL-33 in cardiovascular diseases have been reported. For example, IL-33 can reduce the development of atherosclerosis in apolipoprotein E Ϫ/Ϫ mice on a high-fat diet. 5 Furthermore, IL-33/ST2 complexes also have been shown to activate cardioprotective signaling pathways. 6 IL-33 is produced as a 30-kDa precursor protein that is cleaved in vitro by caspase-1, releasing the mature 18-kDa form. 4 Upon binding to the ST2 receptor, IL-33 promotes the activation of nuclear factor (NF)-B and mitogen-activated protein kinase (MAPK), leading to increased transcription of Th2 cytokines. 4 The ST2 receptor, a member of IL-1 receptor family, has long been known as an orphan receptor. Despite its structural and functional similarity to IL-1 receptor family, the ST2 receptor does not bind to IL-1␣ or IL-1␤ or other members of the IL-1 family. Two isoforms, a soluble (sST2) and a membrane bound form (ST2L), are produced through differential mRNA processing. 7,8 ST2L is expressed mainly in mast cells and Th2 cells. 7,8 Both ST2 forms also are expressed in freshly isolated human umbilical vein endothelial cells (HUVECs), and they are up-regulated by proinflammatory stimuli such as TNF, IL-1␣, and IL-1␤. 9 Nitric oxide (NO) production in endothelial cells (ECs) is transiently regulated by multiple inflammatory angiogenic factors such as VEGF and angiopoietin-1. 10,11 NO, in turn, modulates the angiogenic function of these ...

The transcription factor Elf5 plays an important role in mammary gland development. However, because of the embryonic lethality of Elf5 straight knockout mice, prior studies have been limited to experiments with Elf5 haploinsufficient animals, overexpression systems or transplants. Here, we have utilized K14-Cre to generate mammary-gland specific Elf5 conditional knockout mice. During pregnancy, Elf5-null mammary epithelium completely failed to initiate alveologenesis, and a characteristic of virgin ductal epithelial cells persisted postpartum. We demonstrate that the loss of Elf5 leads to the absence of alveolar secretory markers confirming previous published data. Interestingly, the developmental block due to a lack of Elf5 could not be restored by multiple gestations. Elf5-null mammary epithelial cells also display disorganized cell structures as evident by altered cell polarities, which might be the cause for collapsed lumina. We observe reduced levels of Stat5 and attenuated Stat5 activity as measured by p-Stat5 levels both in Elf5-null mammary glands as well as cultured mammary epithelial cells. This data suggests that the failure of alveolar and lactogenic differentiation due to the loss of Elf5 is mediated in part due to impaired Stat5 activity. In support of this hypothesis, we show by ChIP experiments that Stat5a promoter contains a conserved Elf5-binding site that is occupied by Elf5 in mammary glands. Mammary epithelia lacking Elf5 exhibited downregulation of several other critical genes involved in alveologenesis, suggesting Elf5 as a master regulator in alveolar development. We propose a model for Elf5-mediated alveolar development, in which Elf5 regulates the expression of key mediators of the PrlR/Jak2/Stat5 signaling pathway.

Regenerative therapy of the salivary gland (SG) is a promising therapeutic approach for irreversible hyposalivation in patients with head and neck cancer treated by radiotherapy. However, little is known about the molecular regulators of stem/progenitor cell activity and regenerative processes in the SG. Wnt/β-catenin signaling regulates the function of many adult stem cell populations, but its role in SG development and regeneration is unknown. Using BAT-gal Wnt reporter transgenic mice, we demonstrate that in the submandibular glands (SMGs) of newborn mice Wnt/β-catenin signaling is active in a few cells at the basal layer of intercalated ducts, the putative location of salivary gland stem/progenitor cells (SGPCs). Wnt activity decreases as mice age, but is markedly enhanced in SG ducts during regeneration of adult SMG after ligation of the main secretory duct. The Hedgehog (Hh) pathway is also activated after duct ligation. Inhibition of epithelial β-catenin signaling in young Keratin5-rtTA/tetO-Dkk1 mice impairs the postnatal development of SMG, particularly affecting maturation of granular convoluted tubules. Conversely, forced activation of epithelial β-catenin signaling in adult Keratin5-rtTA/tetO-Cre/Ctnnb1((Ex3)fl) mice promotes proliferation of ductal cells, expansion of the SGPC compartment, and ectopic activation of Hh signaling. Taken together, these results indicate that Wnt/β-catenin signaling regulates the activity of SGPCs during postnatal development and regeneration upstream of the Hh pathway, and suggest the potential of modulating Wnt/β-catenin and/or Hh pathways for functional restoration of SGs after irradiation.

No abstract